These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
595 related articles for article (PubMed ID: 9657975)
1. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents. Pascaud C; Garrigos M; Orlowski S Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975 [TBL] [Abstract][Full Text] [Related]
2. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model. Garrigos M; Mir LM; Orlowski S Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038 [TBL] [Abstract][Full Text] [Related]
3. Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators. Orlowski S; Mir LM; Belehradek J; Garrigos M Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):515-22. PubMed ID: 8713080 [TBL] [Abstract][Full Text] [Related]
4. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein. Shepard RL; Winter MA; Hsaio SC; Pearce HL; Beck WT; Dantzig AH Biochem Pharmacol; 1998 Sep; 56(6):719-27. PubMed ID: 9751076 [TBL] [Abstract][Full Text] [Related]
5. Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335). Chen KG; Lacayo NJ; Durán GE; Cohen D; Sikic BI Mol Pharmacol; 2000 Apr; 57(4):769-77. PubMed ID: 10727524 [TBL] [Abstract][Full Text] [Related]
6. Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells. Malkhandi J; Ferry DR; Boer R; Gekeler V; Ise W; Kerr DJ Eur J Pharmacol; 1994 Dec; 288(1):105-14. PubMed ID: 7705462 [TBL] [Abstract][Full Text] [Related]
7. The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2. Shukla S; Robey RW; Bates SE; Ambudkar SV Biochemistry; 2006 Jul; 45(29):8940-51. PubMed ID: 16846237 [TBL] [Abstract][Full Text] [Related]
8. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system. Ramachandra M; Ambudkar SV; Gottesman MM; Pastan I; Hrycyna CA Mol Biol Cell; 1996 Oct; 7(10):1485-98. PubMed ID: 8898356 [TBL] [Abstract][Full Text] [Related]
9. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles. Horio M; Lovelace E; Pastan I; Gottesman MM Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642 [TBL] [Abstract][Full Text] [Related]
10. Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil. Safa AR Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7187-91. PubMed ID: 2902625 [TBL] [Abstract][Full Text] [Related]
11. Allosteric regulation of [3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine. Ferry DR; Malkhandi PJ; Russell MA; Kerr DJ Biochem Pharmacol; 1995 Jun; 49(12):1851-61. PubMed ID: 7598747 [TBL] [Abstract][Full Text] [Related]
12. Interaction of the P-glycoprotein multidrug transporter with peptides and ionophores. Sharom FJ; DiDiodato G; Yu X; Ashbourne KJ J Biol Chem; 1995 Apr; 270(17):10334-41. PubMed ID: 7730340 [TBL] [Abstract][Full Text] [Related]
13. Expression and function of P-glycoprotein and absence of multidrug resistance-related protein in rat and beige mouse peritoneal mast cells. Candussio L; Crivellato E; Rosati AM; Klugmann FB; Granzotto M; Giraldi T; Decorti G Histochem J; 2001 May; 33(5):259-66. PubMed ID: 11563538 [TBL] [Abstract][Full Text] [Related]
14. Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein. Höllt V; Kouba M; Dietel M; Vogt G Biochem Pharmacol; 1992 Jun; 43(12):2601-8. PubMed ID: 1352973 [TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding site. Ferry DR; Russell MA; Cullen MH Biochem Biophys Res Commun; 1992 Oct; 188(1):440-5. PubMed ID: 1358068 [TBL] [Abstract][Full Text] [Related]
16. Drug accumulation in the presence of the multidrug resistance pump: dissociation between verapamil accumulation and the action of P-glycoprotein. Ayesh S; Litman T; Stein WD Recept Channels; 1997; 5(3-4):175-83. PubMed ID: 9606721 [TBL] [Abstract][Full Text] [Related]
17. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells. Tamai I; Safa AR J Biol Chem; 1991 Sep; 266(25):16796-800. PubMed ID: 1679434 [TBL] [Abstract][Full Text] [Related]
18. Detailed characterization of cysteine-less P-glycoprotein reveals subtle pharmacological differences in function from wild-type protein. Taylor AM; Storm J; Soceneantu L; Linton KJ; Gabriel M; Martin C; Woodhouse J; Blott E; Higgins CF; Callaghan R Br J Pharmacol; 2001 Dec; 134(8):1609-18. PubMed ID: 11739236 [TBL] [Abstract][Full Text] [Related]
19. Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity. Litman T; Zeuthen T; Skovsgaard T; Stein WD Biochim Biophys Acta; 1997 Aug; 1361(2):169-76. PubMed ID: 9300798 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the azidopine and vinblastine binding site of P-glycoprotein. Bruggemann EP; Currier SJ; Gottesman MM; Pastan I J Biol Chem; 1992 Oct; 267(29):21020-6. PubMed ID: 1356986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]